This assay is useful to provide an estimate of prognosis (aggressiveness of disease) of Bcell chronic lymphocytic leukemia (BCLL) and to help evaluate treatment options.BCLL with mutated IgVH is typically less aggressive (more slowly progressive) than BCLL with unmutated IgVH.
Sample Type - Blood
Reporting Time - Please Call Customer care
Prerequisites - No special preparation required
Price - ₹13310/-
Add to cart Go Home